Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial

Peroxisome proliferator-activated receptor gamma (PPAR-γ) is a nuclear receptor that modulates inflammation in models of asthma. To determine whether pioglitazone improves measures of asthma control and airway inflammation, we performed a single-center randomized, double-blind, placebo-controlled, p...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	PloS one Ročník 11; číslo 8; s. e0160257
Hlavní autori:	Anderson, J. R., Mortimer, K., Pang, L., Smith, K. M, Bailey, H., Hodgson, D. B., Shaw, D. E., Knox, A. J., Harrison, T. W.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Public Library of Science 25.08.2016 Public Library of Science (PLoS)
Predmet:	Adult Aged Airway management Allergies Asthma Asthma - drug therapy Asthma - metabolism Asthma - physiopathology Biology and Life Sciences Bladder Bladder cancer Cancer Chemokine CCL2 - analysis Chemokine CXCL10 - analysis Clinical trials Confidence intervals Control methods Diabetes Double-Blind Method Double-blind studies Drug therapy Eosinophil cationic protein Eosinophil Cationic Protein - analysis Ethics Female Health risks Humans Hypoglycemic Agents - therapeutic use Inflammation Interferon IP-10 protein Male Medicine and Health Sciences Metabolism Middle Aged Monocyte chemoattractant protein 1 Nitric oxide Peroxisome proliferator-activated receptors Physical Sciences Pioglitazone Pneumonia - drug therapy Pneumonia - metabolism Pneumonia - physiopathology PPAR gamma - agonists PPAR gamma - metabolism Quality of Life Randomization Recruitment Research and Analysis Methods Respiratory Function Tests - methods Respiratory tract Respiratory tract diseases Sputum Sputum - metabolism Surveys and Questionnaires Thiazolidinediones - therapeutic use Time Factors Treatment Outcome Tumor necrosis factor-TNF Urinary bladder Vascular endothelial growth factor Vascular Endothelial Growth Factor A - analysis Young Adult
ISSN:	1932-6203, 1932-6203
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!